Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

Bjorn Gudbjornsson,1,2 Arni Jon Geirsson,3,4 Niels Steen Krogh5 1Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland; 2Faculty of Medicine, University of Iceland, Reykjavik, Iceland; 3Department of Rheumatology, University Hospital, Reykjavik, Iceland; 4Laeknasetrid - Medical C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gudbjornsson B, Geirsson AJ, Krogh NS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Psoriatic Arthritis
outcome
biological treatment
routine care
clinical nationwide registry
Dermatology
RL1-803
Acceso en línea:https://doaj.org/article/1a2d9fd70fe74e35857fdaad12c0dba2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/1a2d9fd70fe74e35857fdaad12c0dba2

Ejemplares similares